Pillar Biosciences
Beckman Coulter Life Sciences, Pillar Biosciences to Develop NGS Cancer Tests
Pillar will develop a series of tests for use on Beckman Coulter's Biomek NGeniuS Next Generation Library Preparation System.
Illumina, Pillar Biosciences Ink Global Distribution Agreement for Cancer Dx Assays
The firms said their distribution deal will facilitate the integration of Pillar's precision oncology assays and Illumina's sequencers.
Pillar Biosciences Licenses KeyGene NGS IP
The intellectual property relates to the use of a combination of two or more nucleotide sequence identifiers in the preparation of a sample DNA for high-throughput sequencing.
Beckman Coulter Life Sciences, Pillar Biosciences Partner to Develop NGS Solutions
Under the agreement, Pillar Biosciences will develop applications designed for Beckman Coulter's Biomek NGenius System.
Pillar Biosciences Receives China Approval for Colon Cancer Companion Diagnostic Assay
The OncoReveal Dx Colon Cancer Assay is intended for use on the Illumina MiSeq Dx, and now has approvals in China, the US, and Europe.